Loading…

Chemours Co.CCCompetitor analysis, valuation and peers

United States · USD·Materials›Chemicals: Specialty

Makes fluoroproducts (refrigerants, Teflon) and titanium dioxide pigments for industrial and consumer applications, spun off from DuPont.

Momentum laggard 19
Mkt cap
$1.82B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$32.2M
20-day average traded
Fwd P/E
7.8×
forward earnings
ROIC−WACC
-3.5 pp
WACC 7.7%
Hurdle
+12 pp
Req g minus delivered
Official | Implied
BB- / B+
agencies · bond market
Next earnings
85 days
11 Feb 2027
Close · USD$12.09
1D-0.7%
1W-11.9%
1M-6.8%
3M-22.9%
6M-45.7%
YTD+2.5%
1Y+7.5%
ATR %5.2%
Beta1.44
52w lowhigh57.8% off high

What Chemours does

Makes fluoroproducts (refrigerants, Teflon) and titanium dioxide pigments for industrial and consumer applications, spun off from DuPont.

Titanium dioxide, a white pigment used in paint and plastics, is sold at prices that rise and fall with supply, while refrigerants and fluoropolymers are more specialised and protected by patents on newer low-warming refrigerants. Legacy PFAS (so-called forever chemicals) liabilities are shared with DuPont and Corteva under a 2021 cost-sharing agreement.

Products and services

  • Titanium dioxide (Ti-Pure pigments)
  • Fluoroproducts (Opteon refrigerants, Teflon)
  • Thermal & Specialized Solutions

Customers

  • Paint/coatings manufacturers
  • HVAC/refrigeration equipment makers
  • Industrial manufacturers

Where it sits in the supply chain

  • Materials
  • Chemicals: Specialty
  • Fluoroproducts and titanium dioxide

What could go right

  • Global HVAC refrigerant transition under low-GWP regulations
  • TiO2 price cycle recovery

What could go wrong

  • PFAS litigation and remediation liabilities
  • TiO2/commodity chemical price cyclicality

Moat: narrow (IP / patents, scale, process know-how). Large-scale TiO2 and fluorochemical production with patented low-GWP refrigerant technology, though facing PFAS litigation liability.

Headquarters: Wilmington, Delaware, US · Founded: 2015 · Employees: 5,700

Named competitors

Chemours at a glance

Size Chemours (CC) is a United States Materials company (Chemicals: Specialty) with a market value of $1.82B, the 1834th largest of 3,085 United States companies the cockpit tracks. Shares closed at $12.09 on 18 Nov 2026.

Performance Over six months the shares fell 45.7%, against -26.0% for the median peer and -2.2% for the United States market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue fell 0.5% over the last twelve months (peer median +17.1%); the operating margin is 3.2% (peer median 9.5%).

Valuation It trades at 7.8× forward earnings against a peer median of 19.2× (2nd cheapest of 18).

Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +12 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.5 points below its cost of capital (7.7% WACC).

Backlog Backlog (remaining performance obligations) was $98.0M at 30 Sep 2026, down 46% on a year earlier — 0.0 years of trailing revenue. Backlog detail →

Credit Chemours has 3 bonds outstanding ($1.81B), rated BB- by the agencies and trading like B+ at a weighted spread of 330 bp.

Short interest Short interest is 9.7% of the free float (30 Oct 2026).

Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).

Relative performance

608010012021 May 202621 Aug 202618 Nov 2026Peer median 73CC 56
Six months, rebased to 100: Chemours against the median of its 20 peers (local-currency closes).

Chemours financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$5.84B$5.81B$5.78B$6.08B$6.79B
Revenue growth—0%-5%-11%—
Gross profit$882M$901M$1.14B$1.31B$1.64B
EBITDA$504M$654M$735M$812M$1.10B
Net income-$168M-$386M$69.0M-$238M$578M
Free cash flow$211M$51.0M-$993M$186M$447M
Capital expenditure$189M$213M$360M$370M$307M
Total debt$4.09B$4.39B$4.37B$4.30B$3.88B

Quarterly statements and history in the cockpit →

Chemours competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%-20%-10%68826801894368MTX6880053006550022500024086038230020104208603067GRWRHITECH603002301219601568002145603938600500CC6-month return →1-month return →
Up and to the right = strong over both horizons. Chemours is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%+75%0×100×200×68826801894368MTX688005300655002250002408603823002010603067GRWRHITECH603002301219601568CCRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Chemours is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%68826801894368MTX002250002408603823GRWRHITECH601568600500CCGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Chemours is the large dot.

Chemours competitors and peer comparison

Head to head with its named competitors (CC vs TROX vs HON vs KRO)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Chemours CC$1.82B-46%-1%3%7.8×15.2%
Tronox TROXn/a-81%n/an/an/an/a
Honeywell Technologies HON$70.7B-2%-17%18%23.5×4.7%
Kronos Worldwide KRO$869M+16%+9%3%18.9×11.9%

How Chemours compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Chemours against its 20 peers (data as of 18 Nov 2026)
MeasureCCPeer medianRank in peer set
1-month return-6.8%-13.2%7th highest of 21
6-month return-45.7%-26.0%5th lowest of 21
Distance from 52-week high-57.8%-56.2%9th lowest of 21
Revenue growth (TTM)-0.5%+17.1%4th lowest of 21
Operating margin3.2%9.5%5th lowest of 21
Forward P/E7.8×19.2×2nd cheapest of 18
Growth the price implies (Req g, 7 yrs)15.2%9.7%4th most demanding of 11
Growth delivered (Del g)+3.2%+5.8%5th lowest of 11
Hurdle (Req g minus delivered)+12.0 pp+8.1 pp6th least demanding of 11
ROIC minus cost of capital-3.5 pp-1.4 pp5th lowest of 21
EV / EBITDA10.3×9.5×4th cheapest of 7
Net debt / EBITDA6.7×-1.3×most indebted of 7
Bond spread330 bpn/a—

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Chemours CCUnited States$1.82B-46%-1%3%7.8×15.2%+3.2%
Guangdong Huate Gas 688268.SSChina$1.82B-50%+27%13%53.1×34.7%+7.2%
Dongyue 0189.HKHong Kong$1.82B-24%+8%19%5.2×-13.6%+6.6%
Fuso Chemical 4368.TJapan$1.81B-32%+17%26%13.1×9.0%+12.8%
Minerals Technologies MTXUnited States$1.85B-22%+5%13%9.4×0.4%+5.4%
Ningbo Ronbay New Energy Technology 688005.SSChina$1.79B-51%+41%1%42.3×n/an/a
Crystal Clear Electronic Material 300655.SZChina$1.78B-33%+27%7%69.6×n/an/a
Lianhe Chemical Technology 002250.SZChina$1.77B-14%+28%13%18.4×-4.2%+6.1%
Zibo Qixiang Tengda Chemical 002408.SZChina$1.77B-28%+18%-1%207.5×3.1%-0.8%
Lily 603823.SSChina$1.76B+39%+2%10%53.7×26.5%+1.4%
Transfar Zhilian 002010.SZChina$1.74B-20%-30%5%15.0×n/an/a
Ube 4208.TJapan$1.94B+34%+8%5%11.9×n/an/a
Inner Mongolia Shuangxin Environment-Friendly Material 001369.SZChina$1.70B-36%+3%15%n/an/an/a
Hubei Zhenhua Chemical 603067.SSChina$1.95B-55%+31%11%19.2×n/an/a
Garware Hi-Tech Films GRWRHITECH.NSIndia$1.95B+42%+15%21%38.7×39.5%+16.6%
Epoxy Base Electronic Material 603002.SSChina$1.98B-22%+73%7%64.6×n/an/a
Ganzhou Teng Yuan Cobalt New Material 301219.SZChina$1.67B-55%+64%10%11.3×n/an/a
Shaanxi Beiyuan Chemical Industry 601568.SSChina$1.99B-13%-8%-4%11.1×10.5%-1.8%
Tinergy Chemical 002145.SZChina$2.06B-20%+17%9%n/an/an/a
Tangshan SunFar Silicon Industries 603938.SSChina$1.61B-30%+30%8%40.1×n/an/a
Sinochem International 600500.SSChina$2.06B-31%-5%-1%n/a11.0%-2.7%

Chemours bonds and credit

Chemours has 3 bonds outstanding with $1.81B face value. The agencies rate it BB-; its bonds trade like B+. Weighted yield 7.94%, a spread of 330 bp over government bonds.

Every bond, yield and spread in the cockpit →

Chemours backlog

Chemours reported $98.0M of remaining performance obligations at 30 Sep 2026, down 46% from a year earlier and down 20% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 0.98.

Questions

Who are Chemours's main competitors?
Named competitors: Tronox (TROX), Honeywell (Solstice refrigerants) (HON), Kronos Worldwide (KRO). The cockpit's measured peer set (industry) also includes Guangdong Huate Gas (688268.SS), Dongyue (0189.HK), Fuso Chemical (4368.T), Minerals Technologies (MTX), Ningbo Ronbay New Energy Technology (688005.SS), Crystal Clear Electronic Material (300655.SZ).
Is Chemours expensive compared with its peers?
On forward p/e it trades at 7.8× against a peer median of 19.2×, 2nd cheapest of 18 in its peer set. For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +12 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Chemours stock performed?
Over six months to 18 Nov 2026 the shares returned -45.7% against -26.0% for the median peer; over one year +7.5%.
What is Chemours's backlog?
Chemours's remaining performance obligations (contracted revenue not yet recognised) were $98.0M at 30 Sep 2026, -46% on a year earlier.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.